Medecins Sans Frontieres: 870m Vaccine Doses Being Hoarded by 10 Rich Countries – ‘Tragedy’ for Those Deprived of Jabs 08/10/2021 Madeleine Hoecklin The hoarding of more than 870 million excess doses of COVID-19 vaccines in just 10 high-income countries is likely to deprive hundreds of millions of healthcare workers and vulnerable populations in low- and middle-income countries of the opportunity to get even a first vaccine dose, according to a new report by Medecins Sans Frontieres (MSF). […] Continue reading -> After a “Lost Decade” – New WHO Alcohol Action Plan Offers Historic Chance to Address Health Risk to Billions 08/10/2021 Kristina Sperkova Long months of pandemic lockdown have only exacerbated the harms due to alcohol experienced by billions of people worldwide. Now, WHO is in the process of developing a new alcohol action plan, in an effort to re-energize a stagnant process and overcome a “lost decade” of little progress on alcohol policies. Can it make a […] Continue reading -> WHO Believes 70% Vaccination Target is Possible – But Only if Wealthy Countries Make Way for COVAX and Africa 07/10/2021 Kerry Cullinan The World Health Organization (WHO) believes that is possible to get 70% of the world vaccinated against COVID-19 by June – but only if wealthy countries redirect their doses and orders to poorer countries that are lagging behind. Eleven billion vaccines are needed to reach the 70% target, said WHO Director-General Dr Tedros Adhanom Ghebreyesus […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> Posts navigation Older Posts Newer Posts
After a “Lost Decade” – New WHO Alcohol Action Plan Offers Historic Chance to Address Health Risk to Billions 08/10/2021 Kristina Sperkova Long months of pandemic lockdown have only exacerbated the harms due to alcohol experienced by billions of people worldwide. Now, WHO is in the process of developing a new alcohol action plan, in an effort to re-energize a stagnant process and overcome a “lost decade” of little progress on alcohol policies. Can it make a […] Continue reading -> WHO Believes 70% Vaccination Target is Possible – But Only if Wealthy Countries Make Way for COVAX and Africa 07/10/2021 Kerry Cullinan The World Health Organization (WHO) believes that is possible to get 70% of the world vaccinated against COVID-19 by June – but only if wealthy countries redirect their doses and orders to poorer countries that are lagging behind. Eleven billion vaccines are needed to reach the 70% target, said WHO Director-General Dr Tedros Adhanom Ghebreyesus […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> Posts navigation Older Posts Newer Posts
WHO Believes 70% Vaccination Target is Possible – But Only if Wealthy Countries Make Way for COVAX and Africa 07/10/2021 Kerry Cullinan The World Health Organization (WHO) believes that is possible to get 70% of the world vaccinated against COVID-19 by June – but only if wealthy countries redirect their doses and orders to poorer countries that are lagging behind. Eleven billion vaccines are needed to reach the 70% target, said WHO Director-General Dr Tedros Adhanom Ghebreyesus […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> Posts navigation Older Posts Newer Posts
Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> Posts navigation Older Posts Newer Posts
WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> Posts navigation Older Posts Newer Posts
African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> Posts navigation Older Posts Newer Posts
African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> Posts navigation Older Posts Newer Posts
Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> Posts navigation Older Posts Newer Posts
A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> Posts navigation Older Posts Newer Posts
Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> Posts navigation Older Posts Newer Posts